Dr. Bob T. Li MBBS, MPH, FRACP
Oncologist | Medical Oncology
300 E 66th St Memorial Sloan Kette New York NY, 10065About
Dr. Bob Li is an oncologist practicing in New York, NY. Dr. Li specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Li manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Enduring complete metabolic response in metastatic adenocarcinoma of the gastro-oesophageal junction.
- Dramatic response to selective internal radiation therapy for unresectable hepatocellular carcinoma.
- Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report.
- Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted Therapy.
- Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice.
- Measurement of preoperative lobar lung function with computed tomography ventilation imaging: progress towards rapid stratification of lung cancer lobectomy patients with abnormal lung function.
- Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors.
- What does the future hold for immunotherapy in cancer?
- Systematic Review and Meta-Analysis on the Role of Chemotherapy in Advanced and Metastatic Neuroendocrine Tumor (NET).
- PET monitoring of liver directed selective internal radionuclide therapy for metastatic gastro-oesophageal cancer.
- Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers.
- Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
- Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA.
- Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer.
- Correlating Ki67 and other prognostic markers with Oncotype DX recurrence score in early estrogen receptor-positive breast cancer.
Clinical Trials
Dr. Bob T. Li MBBS, MPH, FRACP's Practice location
Dr. Bob T. Li MBBS, MPH, FRACP's reviews
Write ReviewRecommended Articles
- What Specialist Treats Ovarian Cancer?
Ovarian cancer is very difficult to diagnose, and many women feel mild symptoms or no symptoms at all in the early stages of the disease. A whole team of doctors can help with diagnosing and treating ovarian cancer, including the family doctor, gynecologist, and oncologist. Some women have that luck...
- Breast Cancer: New Research Confirms Deodorant Use Is Okay During Radiotherapy
Antiperspirant is okay to wear while undergoing radiation treatment. That’s the finding from a recent study by the Perelman School of Medicine at the University of Pennsylvania.The study also concluded many doctors continue to advise patients against use of antiperspirants during radiotherapy, to...
- Why Clinical Trials Are Essential for Advancement in Ovarian Cancer Treatment
Women who have ovarian cancer need to understand that the best hope for improved screening methods and more effective treatments lies within their participation in clinical trials. Research is the cornerstone of improved medical advances, but work needs to be done at every level and for every stage...
- What Is Liver Cancer: Get the Facts
Liver cancer happens when the liver's normal cells change in behavior and appearance. As a result, the abnormal liver cells divide and grow uncontrollably. Liver cancer is also referred to as "hepatic cancer", which can either be primary or secondary. The liver is a large organ that is located...
- What Primary Care Providers Need to Know About Ovarian Cancer
In the United States, there will be 22,440 women diagnosed with ovarian cancer in 2017 and over half of those cases will be fatal, according to the American Cancer Society. For women, ovarian cancer is the fifth leading cause of cancer deaths. And a woman’s risk of developing ovarian cancer in her...
- Researches Discover Clues as to Why Exactly BRCA Mutations Can Cause Cancer
When the BRCA1 gene mutation was found by scientists supported by the National Cancer Institute to be hereditary predisposition to breast cancer, it was a major breakthrough; however, for many years, researchers have found themselves puzzled by the BRCA1 gene. Its ability to cause breast and ovarian...
Nearby Providers
- Dr. Donna McNamara MD92 2nd Street Hackensack NJ 07601
- Howard W. Bruckner2330 Eastchester Rd Bronx New York 10469
- Dr. William H. Nealon M.D.450 Lakeville Road New Hyde Park NY 11042
- Dr. Trevor Joseph Layne MD354 MAIN ST WEST ORANGE NJ 07052
- Rachel Beth Wellner1185 Park Ave New York NY 10128
- Orestes Sanchez703 Main St Paterson New Jersey 07503